| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/13/2001 | CA2810249A1 Identification and use of human bone marrow-derived endothelial progenitor cell to improve myocardial function after ischemic injury |
| 12/13/2001 | CA2414076A1 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 12/13/2001 | CA2412436A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2411730A1 Tumour suppressor and uses thereof |
| 12/13/2001 | CA2411575A1 Immunostimulatory oligodeoxynucleotides |
| 12/13/2001 | CA2411536A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| 12/13/2001 | CA2411473A1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 12/13/2001 | CA2411470A1 T cell receptor fusions and conjugates and methods of use thereof |
| 12/13/2001 | CA2411432A1 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs |
| 12/13/2001 | CA2411430A1 A method of treatment of parkinson's disease with a protein extractable from mammalian organs |
| 12/13/2001 | CA2411429A1 A method of treatment of huntington's chorea with a protein extractable from mammalian organs |
| 12/13/2001 | CA2411428A1 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs |
| 12/13/2001 | CA2411396A1 Hmg coa reductase inhibitors for promoting angiogenesis |
| 12/13/2001 | CA2411354A1 Methods of treating viral diseases with il-18 and il-18 combinations |
| 12/13/2001 | CA2411285A1 Combined preparation for the treatment of neoplasic diseases |
| 12/13/2001 | CA2411101A1 A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 12/13/2001 | CA2411067A1 Oligopeptides for promoting hair growth |
| 12/13/2001 | CA2411062A1 Benzamide ligands for the thyroid receptor |
| 12/13/2001 | CA2411017A1 Epididymis-specific proteins with fibronectin type ii modules |
| 12/13/2001 | CA2410938A1 Recombinant subunit proteins from porcine parvovirus produced in plants |
| 12/13/2001 | CA2410158A1 Protein markers for pharmaceuticals and related toxicity |
| 12/13/2001 | CA2410052A1 Delivery systems for bioactive agents |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409342A1 Extracellular messengers |
| 12/13/2001 | CA2409287A1 Hepatitis c virus conjugates |
| 12/13/2001 | CA2409268A1 Macromolecular drug complexes and compositions containing the same |
| 12/13/2001 | CA2409197A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/13/2001 | CA2408670A1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 12/13/2001 | CA2408611A1 Kits and methods for optimizing the efficacy of chondroprotective compositions |
| 12/13/2001 | CA2408610A1 Low carbohydrate compositions, kits thereof, and methods of use |
| 12/13/2001 | CA2408609A1 Compositions, kits, and methods for promoting defined health benefits |
| 12/13/2001 | CA2398277A1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity |
| 12/12/2001 | EP1162273A1 Recombinant DNA vectors for gene therapy |
| 12/12/2001 | EP1162269A1 Novel polypeptide |
| 12/12/2001 | EP1162265A2 Human PEM as a target for fertility control and Alzheimer therapy |
| 12/12/2001 | EP1162263A1 Nucleozymes |
| 12/12/2001 | EP1162207A1 Amylin agonist peptides and uses therefor |
| 12/12/2001 | EP1162206A2 Peptide nucleic acids |
| 12/12/2001 | EP1161957A1 Complex for transferring an anionic substance of interest into a cell |
| 12/12/2001 | EP1161955A2 Induction of immunological tolerance for graft transplantation by the use of humanized non-depleting anti-cd4 antibodies in combination with specific donor bone marrow cells |
| 12/12/2001 | EP1161954A1 Treatment of T cell mediated autoimmune disorders |
| 12/12/2001 | EP1161952A2 Human therapeutic uses of BPI protein products |
| 12/12/2001 | EP1161951A1 Selenocosmia huwena toxin and analgesic uses thereof |
| 12/12/2001 | EP1161947A2 Oral antibacterial compositions and method for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics |
| 12/12/2001 | EP1161943A2 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
| 12/12/2001 | EP1161547A1 Intravascular delivery of non-viral nucleic acid |
| 12/12/2001 | EP1161542A1 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans |
| 12/12/2001 | EP1161535A1 Rna polymerase i transcription factor tif-ia |
| 12/12/2001 | EP1161534A1 Differential expression of organellar gene products |
| 12/12/2001 | EP1161532A1 Human serpin proteins |
| 12/12/2001 | EP1161531A1 Tumor-associated antigen |
| 12/12/2001 | EP1161530A1 Protein for blocking platelet adhesion |
| 12/12/2001 | EP1161525A2 Methods and compositions for regulating memory consolidation |
| 12/12/2001 | EP1161524A2 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN $g(a)-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS |
| 12/12/2001 | EP1161456A2 Antibody and chemokine constructs and their use for treating autoimmune diseases |
| 12/12/2001 | EP1161455A1 A novel chimeric protein for prevention and treatment of hiv infection |
| 12/12/2001 | EP1161454A2 Peptides with anti-angiogenic activity |
| 12/12/2001 | EP1161452A2 Covalently bridged insulin dimers |
| 12/12/2001 | EP1161451A2 Human endokine alpha and methods of use |
| 12/12/2001 | EP1161450A1 Bone stimulating factor |
| 12/12/2001 | EP1161449A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 12/12/2001 | EP1161448A1 49 human secreted proteins |
| 12/12/2001 | EP1161447A1 50 human secreted proteins |
| 12/12/2001 | EP1161446A1 50 human secreted proteins |
| 12/12/2001 | EP1161445A2 Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
| 12/12/2001 | EP1161442A2 Exocytosis pathway proteins and methods of use |
| 12/12/2001 | EP1161441A1 Compositions for promoting nerve regeneration |
| 12/12/2001 | EP1161440A1 Method for refolding molecules of polypeptides containing ig domains |
| 12/12/2001 | EP1161433A1 Tyrosine kinase inhibitors |
| 12/12/2001 | EP1161431A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 12/12/2001 | EP1161421A1 Inhibitors of protein tyrosine phosphatase |
| 12/12/2001 | EP1161418A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 12/12/2001 | EP1161279A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin |
| 12/12/2001 | EP1161266A1 Matriptase, a serine protease and its applications |
| 12/12/2001 | EP1161262A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS |
| 12/12/2001 | EP1161261A1 Apoptosis inducing molecule ii and methods of use |
| 12/12/2001 | EP1161258A1 Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease |
| 12/12/2001 | EP1161257A2 Pharmaceutical compositions comprising tgf-beta |
| 12/12/2001 | EP1161256A1 Use of nerve growth factor for therapy of intraocular tissue pathologies |
| 12/12/2001 | EP1161255A2 Methods and compositions for treating erectile dysfunction |
| 12/12/2001 | EP1161250A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 12/12/2001 | EP1161230A1 Transdermal therapy system and method for producing the same |
| 12/12/2001 | EP1161153A1 Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency |
| 12/12/2001 | EP1161149A1 Ng2/hm proteoglycan-binding peptides that home to angiogenic vasculature and related methods |
| 12/12/2001 | EP1161147A1 Peptide mimics useful for treating disease |
| 12/12/2001 | EP1161142A1 Methods for culturing fluid-filled sensory organs |
| 12/12/2001 | EP0999851B1 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 12/12/2001 | EP0977584B1 PHARMACEUTICAL PREPARATION COMPRISING vWF PROPEPTIDE |
| 12/12/2001 | EP0934329B1 Glycoconjugates from modified camptothecin derivates (20-o-linkage) |
| 12/12/2001 | EP0889730B1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 12/12/2001 | EP0836480B1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof |
| 12/12/2001 | EP0809656B1 MONOCLONAL ANTIBODY SPECIFIC FOR beta-A4 PEPTIDE |
| 12/12/2001 | EP0785788B1 Use of cck-b receptor antagonists for the treatment of sleep disorders |
| 12/12/2001 | EP0782456B1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 12/12/2001 | EP0779805B1 Sustained release of peptides from pharmaceutical compositions |
| 12/12/2001 | EP0766570B1 Methods for treating respiratory disease |
| 12/12/2001 | EP0730465B1 Use of angiotensin iii and analogs thereof in tissue repair |